IndexIQ Advisors’s Core Laboratories CLB Stock Holding History

IndexIQ Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$408K	Buy	+12,907	New	+$362K	0.01%	559
2021 Q1	–	Sell	-20,256	Closed	-$537K	–	1164
2020 Q4	$537K	Buy	20,256 +2,091	+12%	+$42.7K	0.02%	359
2020 Q3	$277K	Buy	18,165 +985	+6%	+$20.7K	0.01%	447
2020 Q2	$349K	Sell	17,180 -2,492	-13%	-$44.7K	0.02%	298
2020 Q1	$203K	Buy	+19,672	New	+$550K	0.01%	291
2013 Q3	–	Sell	-1,344	Closed	-$204K	–	214
2013 Q2	$204K	Buy	+1,344	New	+$190K	0.03%	158

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

CPH

C Partners Holding Zurich, Switzerland $317M AUM 4.76% 1-Year Est. Return

IndexIQ Advisors's CLB Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Core Laboratories (CLB) in Q1 2022: 12,907 shares worth $408K. The stake represents 0.01% of the portfolio and ranks #559 among its holdings. This is a return to the name: IndexIQ Advisors previously reported a position in CLB as recently as Q4 2020.

IndexIQ Advisors first reported a position in CLB in Q2 2013 and has held it in 6 quarters since. The position peaked at $537K in Q4 2020. 196 funds tracked by Wall St. Rank hold CLB as of Q1 2022.

IndexIQ Advisors held 12,907 shares of Core Laboratories worth $408K as of Q1 2022.
Core Laboratories was a new IndexIQ Advisors position in Q1 2022.
Core Laboratories made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #559 holding.
IndexIQ Advisors first reported a position in Core Laboratories in Q2 2013 and has held it in 6 quarters since.
IndexIQ Advisors's Core Laboratories position peaked at $537K in Q4 2020.
196 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.